Harrison Clinical Research GmbH

Harrison Clinical Research
Albrechtstrasse 14
80636 Munich, Germany
Tel: 49-(0)89 - 12 66 80-0
Fax 49-(0)89 - 12 66 80-2444
Homepage: www.harrisonclinical.com

Regulatory Surveillance

Review of country drug, medical device & biotechnological trials legislation

Harrison Clinical Research established the need for updated clinical trials regulatory information with the focus on current regulatory requirements where HCR is responsible for obtaining EC approval and CA authorisation. We have developed a regulatory database with local experts around the world, via a coordinated network. The informations collected are, the required documents for EC/CA submission, country specific regulations and guidelines, and timelines for obtaining EC/CA approvals. Regulatory Surveillance Report data is collected by, local expert review of all relevant Web pages, compilation of all current information into a report and addition of the information into the HCR Regulatory Library.

The report, Regulatory Surveillance Report No: 6, that can be downloaded below, details all changes or additions to regulations, in the 37 countries detailed, since January 2011 and up until end April 2011. New reports will  be issued approximately quarterly. Only changes since the last report are detailed, where there has been no change since the last report in a particular country, this is noted by the term "No change".
As a separate summary the new EU Guidance changes appertaining to - Detailed guidance on the request to the competent authority for authorisation of a clinical trial on a medicinal product for human use, the notification of a substantial amendment and the notification of the end of the trial - have been added as a separate document.

If you would like to download the report, please submit your contact data in the e-mail form below, once you have pressed the "send" button, you will be able to download the Regulatory Surveillance Report No: 6, free-of-charge as a pdf file. If you would like to send us feedback on the current report, please use the comments box in the e-mail form.


 

Personal data:

 

Comments:

 

To finish, please enter the 5-digit security code:


Send E-mail We will be delighted to hear from you.
[ * compulsory fields, please complete ]
 


» Privacy